A Biomarker of Hereditary Transthyretin-Mediated Amyloidosis
Listen now
Description
A discussion of Alnylam's RNAi therapeutic called patiseran for identification of biomarkers associated with the knockdown of a disease-causing protein transthyretin.
More Episodes
Welcome to the Olink® Proteomics in Proximity podcast!  Below are some useful resources mentioned in this episode:    UK Biobank Pharma Proteomics Project (UKB-PPP), one of the world’s largest scientific studies of blood protein biomarkers conducted to date,...
Published 03/05/24
Published 03/05/24
Welcome to the Olink® Proteomics in Proximity podcast! Below are some useful resources mentioned in this episode: Olink tools and software• Olink® Explore 3072, the platform utilized by the UK Biobank to measure ~3000 proteins in plasma: https://olink.com/products-services/explore/• Olink®...
Published 11/16/23